AI designs new antibodies that pass blinded laboratory tests
Researchers affiliated with UTHealth Houston, competing under the team name Novamab AI, placed among the top five teams in the international AIntibody Challenge, a blinded, prospective benchmark published in Nature Biotechnology.
Image: Phys.org
Researchers affiliated with UTHealth Houston, competing under the team name Novamab AI, placed among the top five teams in the international AIntibody Challenge, a blinded, prospective benchmark published in Nature Biotechnology.
Originally published at Phys.org
